|
Q3 FY2026
As of Sep 27, 2026
|
Q2 FY2026
As of Jun 28, 2026
|
Q1 FY2026
As of Mar 29, 2026
|
Q4 FY2025
As of Dec 28, 2025
|
Q3 FY2025
As of Sep 28, 2025
|
Q2 FY2025
As of Jun 29, 2025
|
Q1 FY2025
As of Mar 30, 2025
|
Q4 FY2024
As of Dec 29, 2024
|
Q3 FY2024
As of Sep 29, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Oct 1, 2023
|
Q2 FY2023
As of Jul 2, 2023
|
Q1 FY2023
As of Apr 2, 2023
|
Q4 FY2022
As of Jan 1, 2023
|
Q3 FY2022
As of Oct 2, 2022
|
Q2 FY2022
As of Jul 3, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Marketable securities | ||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||
| Inventories | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Assets held for sale | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||
| Marketable securities | ||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued payroll and related expenses | ||||||||||||||||||
| Income tax payable | ||||||||||||||||||
| Current portion of borrowings | ||||||||||||||||||
| Other current liabilities | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||
| Long-term borrowings | ||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||
| Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at September 27, 2026 and December 28, 2025 | ||||||||||||||||||
| Common stock, $0.001 par value per share; 126.2 shares authorized; 68.6 and 67.9 shares issued and outstanding at September 27, 2026 and December 28, 2025, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...